Image pharmaphorum Editor Digital What HCPs think about medical tweetorials Twitter has been used by health professionals for over a decade to share medical knowledge and education. Views & Analysis COVID-19 has propelled the regulatory industry years ahead Janssen’s Saskia De Haes, VP EMEA Regulatory Affairs, looks at how the pandemic response has shaped tomorrow’s regulatory landscape. News Positive safety data for long-term use of MS drug Kesimpta Multiple sclerosis drug Kesimpta has shown promising safety data for patients who are exposed to it for extended periods. Sales & Marketing Launch excellence: escaping the complexity trap IQVIA’s Sarah Rickwood and Markus Gores look at how to deliver consistent launch performance in an increasingly complex world. Load more results
Digital What HCPs think about medical tweetorials Twitter has been used by health professionals for over a decade to share medical knowledge and education.
Views & Analysis COVID-19 has propelled the regulatory industry years ahead Janssen’s Saskia De Haes, VP EMEA Regulatory Affairs, looks at how the pandemic response has shaped tomorrow’s regulatory landscape.
News Positive safety data for long-term use of MS drug Kesimpta Multiple sclerosis drug Kesimpta has shown promising safety data for patients who are exposed to it for extended periods.
Sales & Marketing Launch excellence: escaping the complexity trap IQVIA’s Sarah Rickwood and Markus Gores look at how to deliver consistent launch performance in an increasingly complex world.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
